{ "items": [ "\n\n
\n \n Conference paper\n \n
\n \n\n \n \n \nSilveira DRARA. et al, (2022), BLOOD, 140, 8698 - 8699
\n \n \n \n\n
\n \n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nTurkalj S. et al, (2022), BLOOD, 140, 1193 - 1194
\n \n \n \n\n
\n \n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nSweeney C. et al, (2022), BLOOD, 140, 1576 - 1578
\n \n \n \n\n
\n \n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nDinardo CD. et al, (2022), JOURNAL OF CLINICAL ONCOLOGY, 40
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nChen JY. et al, (2022), JOURNAL OF CLINICAL ONCOLOGY, 40
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nPapayannidis C. et al, (2022), BLOOD, 140, 11641 - 11643
\n \n \n \n\n
\n \n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nSallman D. et al, (2022), CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 22, S314 - S315
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nSallman DA. et al, (2022), JOURNAL OF CLINICAL ONCOLOGY, 40
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nRisueno A. et al, (2022), BLOOD, 140
\n \n \n \n\n
\n \n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nSchenck RO. et al, (2022), CANCER RESEARCH, 82
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nJohnson L. et al, (2022), BLOOD, 140, 6934 - 6935
\n \n \n \n\n
\n \n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nDiNardo CD. et al, (2022), CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 22, S249 - S250
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nDe Botton S. et al, (2022), JOURNAL OF CLINICAL ONCOLOGY, 40
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nDaver N. et al, (2022), CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 22, S231 - S232
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nChatzikyriakou P. et al, (2022), BLOOD, 140, 3414 - 3415
\n \n \n \n\n
\n \n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nJakobsen NA. et al, (2022), BLOOD, 140, 2227 - 2228
\n \n \n \n\n
\n \n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nDaver N. et al, (2022), CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 22, S253 - S254
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nDaver NG. et al, (2022), JOURNAL OF CLINICAL ONCOLOGY, 40
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nVyas P. et al, (2021), BLOOD, 138
\n \n \n \n\n
\n \n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nDaver N. et al, (2021), BLOOD, 138
\n \n \n \n\n
\n \n \n \n